The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
Open accessAbstract
Background Semaglutide, a GLP-1 receptor agonist, reduces the risk of major adverse cardiovascular events (MACE) in people with overweight or obesity, but the effects of this drug on outcomes in patients with atherosclerotic cardiovascular disease and heart failure are unknown. We report a prespecified analysis of the effect of once-weekly subcutaneous semaglutide 2·4 mg on ischaemic and heart failure cardiovascular outcomes. We aimed to investigate if semaglutide was beneficial in patients with atherosclerotic cardiovascular disease with a history of heart failure compared with placebo; if there was a difference in outcome in patients designated as having heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction; and if the efficacy and safety of semaglutide in patients with heart failure was related to baseline characteristics or subtype of heart failure. Methods The SELECT trial was a randomised, double-blind, multicentre, placebo-controlled, event-driven phase 3 trial in 41 countries. Adults aged 45 years and older, with a BMI of 27 kg/m 2 or greater and established cardiovascular disease were eligible for the study. Patients were randomly assigned (1:1) with a block size of four using an interactive web response system in a double-blind manner to escalating doses of once-weekly subcutaneous semaglutide over 16 weeks to a target dose of 2·4 mg, or placebo. In a prespecified analysis, we examined the effect of semaglutide compared with placebo in patients with and without a history of heart failure at enrolment, subclassified as heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, or unclassified heart failure. Endpoints comprised MACE (a composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death); a composite heart failure outcome (cardiovascular death or hospitalisation or urgent hospital visit for heart failure); cardiovascular death; and all-cause death. The study is registered with ClinicalTrials.gov, NCT03574597. Findings Between Oct 31, 2018, and March 31, 2021, 17 604 patients with a mean age of 61·6 years (SD 8·9) and a mean BMI of 33·4 kg/m 2 (5·0) were randomly assigned to receive semaglutide (8803 [50·0%] patients) or placebo (8801 [50·0%] patients). 4286 (24·3%) of 17 604 patients had a history of investigator-defined heart failure at enrolment: 2273 (53·0%) of 4286 patients had heart failure with preserved ejection fraction, 1347 (31·4%) had heart failure with reduced ejection fraction, and 666 (15·5%) had unclassified heart failure. Baseline characteristics were similar between patients with and without heart failure. Patients with heart failure had a higher incidence of clinical events. Semaglutide improved all outcome measures in patients with heart failure at random assignment compared with those without heart failure (hazard ratio [HR] 0·72, 95% CI 0·60–0·87 for MACE; 0·79, 0·64–0·98 for the heart failure composite endpoint; 0·76, 0·59–0·97 for cardiovascular death; and 0·81, 0·66–1·00 for all-cause death; all p interaction >0·19). Treatment with semaglutide resulted in improved outcomes in both the heart failure with reduced ejection fraction (HR 0·65, 95% CI 0·49–0·87 for MACE; 0·79, 0·58–1·08 for the composite heart failure endpoint) and heart failure with preserved ejection fraction groups (0·69, 0·51–0·91 for MACE; 0·75, 0·52–1·07 for the composite heart failure endpoint), although patients with heart failure with reduced ejection fraction had higher absolute event rates than those with heart failure with preserved ejection fraction. For MACE and the heart failure composite, there were no significant differences in benefits across baseline age, sex, BMI, New York Heart Association status, and diuretic use. Serious adverse events were less frequent with semaglutide versus placebo, regardless of heart failure subtype. Interpretation In patients with atherosclerotic cardiovascular diease and overweight or obesity, treatment with semaglutide 2·4 mg reduced MACE and composite heart failure endpoints compared with placebo in those with and without clinical heart failure, regardless of heart failure subtype. Our findings could facilitate prescribing and result in improved clinical outcomes for this patient group. Funding Novo Nordisk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationSemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Self-citationOnce-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Self-citationEmpagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Self-citationObesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Self-citationSemaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Self-citationSemaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306963 · Cited by 1,669
Self-citationZannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., Brueckmann, M., Ofstad, A. P., Pfarr, E., Jamal, W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31824-9 · Cited by 1,408
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Self-citationSemaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Kosiborod, M. N., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Treppendahl, M. B., Verma, S., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2313917 · Cited by 758
Self-citation
Cited by
Kosiborod, M. N., Deanfield, J., Pratley, R., Borlaug, B. A., Butler, J., Davies, M. J., Emerson, S. S., Kahn, S. E., Kitzman, D. W., Lingvay, I., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01643-x · Cited by 308
Self-citationMozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · Obesity · doi:10.1002/oby.24336 · Cited by 143
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.04.023 · Cited by 154
“In real-world practice, the efficacy for weight reduction is often lower: for example, about 8 % for individuals with diabetes and 11 % for individuals without diabetes at”
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Kittleson, M. M., Benjamin, E. J., Blumer, V., Harrington, J., Januzzi, J. L., McMurray, J. J. V., & Vest, A. R. (2025) · JACC · doi:10.1016/j.jacc.2025.05.008 · Cited by 79
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75
Metadata
- Authors
- Deanfield, J., Verma, S., Scirica, B. M., Kahn, S. E., Emerson, S. S., Ryan, D., Lingvay, I., Colhoun, H. M., Plutzky, J., Kosiborod, M. N., Hovingh, G. K., Hardt-Lindberg, S., Frenkel, O., Weeke, P. E., Rasmussen, S., Goudev, A., Lang, C. C., Urina-Triana, M., Pietilä, M., Lincoff, A. M., Abe, M., Abhaichand, R. K., Abhayaratna, W. P., Abhyankar, A., Abidin, I. B. Z., Abou Assi, H., Accini Mendoza, J. L., Adas, M., Agaiby, J. M., Agarwal, D. K., Agha, M., Ahmed, A., Ahtiainen, P., Aigner, E., Ajay, N., Ali, N., Al-Karadsheh, A., Allison, R., Allison, D. C., Alpenidze, D., Altuntas, Y., Al-Zoebi, A., Ambuj, R., Amerena, J., Anderson, R. J., Ando, T., Andrews, R., Antonova, E., Appel, K.-F., Arantes, F. B., Araz, M., Arbel, Y., Arenas León, J. L., Argyrakopoulou, G., Ariani, M., Arias Mendoza, M. A., Arif, A. A., Arneja, J., Aroda, V. R., Aronne, L. J., Arstall, M., Asamoah, N., Asanin, M., Audish, H., Avram, R., Badat, A., Badiu, C. V., Bakdash, W., Bakiner, O. S., Bandezi, V. N., Bang, L. H., Bansal, S., Baranyai, M., Barbarash, O., Barber, M., Barnum, O., Barone Rochette, G., Bashkin, A., Baum, S., Bays, H. E., Bazzoni Ruiz, A. E., Beckowski, M., Beerachee, Y., Bellary, S., Belousova, L., Berk, M., Bernstein, M., Berra, C., Beshay, I., Bhagwat, A., Bhan, A., Biggs, W. C., Billings, L., Bitar, F., Block, B., Bo, S., Bogdanski, P., Bolshakova, O. O., Boshchenko, A. A., Bosworth, H., Botero Lopez, R., Bôttcher, M., Bourgeois, R., Brautigam, D., Breton, C. F., Broadley, A., Brockmyre, A. P., Brodie, S. K., Bucci, M., Budincevic, H., Budoff, M. J., Buffman, B., Buljubasic, N., Buranapin, S., Burgess, L., Burguera, B., Buriakovska, O., Buscemi, S., Busch, R., Buse, J. B., Buynak, R., Byrne, M., Caceaune, E., Cadena Bonfanti, A. J., Calinescu, C. V., Call, R. S., Canecki Varzic, S., Cannon, K., Capehorn, M., Cariou, B., Carr, J., Carrillo-Jimenez, R., Casas, M., Castro, A., Celik, A., Cercato, C., Cermak, O., Cha, J. Y., Chacon, C., Chaicha-Brom, T., Chandra, S., Chettibi, M., Chevts, J., Christopher, J., Chrustowski, W., Cif, A., Clark, R., Clark, W., Clifford, P., Coetzee, K., Cogni, G., Colao, A. M., Colquhoun, D. M., Concha, M., Condit, J., Constance, C., Constantin, C., Constantinescu, S., Corbett, C., Cornett, G. M., Correia, M., Cortinovis, F., Cosma, D., Creely, S., Cross, D., Curtis, B., Czochra, W., Daboul, N. Y., Dagdelen, S., D'agostino, R., Dang, C., Datta, S., Davuluri, A. K., Dawood, S. Y., De Jong, D. M., De La Cuesta, C., De Los Rios Ibarra, M. O., De Pablo, C., De Pauw, M., Dela Llana, A., Delibasic, M., Delic-Brkljacic, D., Demicheli, T., Denger, R. J., Desai, D., Desai, P., Desouza, C. V., Dicker, D., Djenic, N., Dobson, S., Doi, M., Doran, J. A., Dorman, R., Dotta, F., Dukes, C. E., Duronto, E., Durst, R., Dvoryashina, I. V., Ebrahim, I. O., Eggebrecht, H., Egstrup, K., Ekinci, E. I., Eliasson, B., Eliasson, K., Enache, G., Enculescu, D., English, P., Ermakova, P., Ershova, O., Ezaki, H., Ezhov, M., Farias, E., Farias, J. M., Farsky, P. S., Ferreira, D., Filteau, P., Finneran, M. P., Folkens, E. M., Fonseca, A. G., Fonseca, L., Fordan, S., Fourie, N., França, S., Franco, D. R., Franek, E., Friedman, K., Frittitta, L., Froer, M., Fuckar, K., Fujii, K., Fujita, R., Fukushima, Y., Fulat, M., Fulwani, M., Gajos, G., Galyavich, A., Gambill, M. L., Gandotra, D., Winston, G., Garcia Hernandez, P. A., García Reza, R., Garg, N., Garg, S., Garvey, W. T., Garza, J. C., Gatta-Cherifi, B., Gelev, V., Geller, S. A., Geohas, J. G., Georgiev, B., Ghazi, A., Gilbert, M. P., Gilinskaya, O., Gislason, G., Gogas Yavuz, D., González Albarrán, O., Gordeev, I. G., Gorton, S. C., Goudev, A., Gretland Valderhaug, T., Groenemeijer, B., Gul, I., Gullestad, L., Gurieva, I., Guseva, G. N., Hagenow, A., Haluzik, M., Halvorsen, S., Hammoudi, N., Hanaoka, K., Hancu, N., Hanusch, U., Harris, K., Harris, B., Hartleib, M., Hartman, A. N., Hata, Y., Heimer, B., Herman, L., Herzog, W., Hewitt, E., Heymer, P., Hiremath, S., Hjelmesaeth, J., Høgalmen, R. G., Høivik, H. O., Holmer, H., Horoshko, O., Houser, P. M., Hove, J. D., Hsieh, I.-C., Hulot, J.-S., Hussein, Z., Ilashchuk, T., Ilveskoski, E., Ipatko, I., Iranmanesh, A., Isawa, T., Issa, M., Iteld, B., Iwasawa, T., Jabbar, D., Jackson, R. A., Jackson-Voyzey, E., Jacob, S., Jaffrani, N. A., Jardula, M. F., Jastreboff, A., Jensen, S. E., Jerkins, T., Jimenez-Ramos, S. A., Jitendra Pal Singh, S., Johnson, W., Joyce, J. M., Jozefowska, M., Jugnundan, P., Jungmair, W., Jurowiecki, J., Kadokami, T., Kahali, D., Kahrmann, G., Kaiser, S. E., Kalmucki, P., Kanadasi, M., Kandath, D., Kania, G., Kannan, J., Kapp, C., Karczmarczyk, A., Kartalis, A., Kaser, S., Kasim, S. S., Kastelic, R., Kato, T., Katova, T., Kaul, U., Kautzky-Willer, A., Kawanishi, M., Kayikcioglu, M., Kazakova, E. E., Keeling, P., Kempe, H.-P., Kereiakes, D. J., Kerneis, M., Keski-Opas, T., Khadra, S., Khaisheva, L., Kharakhulakh, M., Khlevchuk, T., Khoo, J., Kiatchoosakun, S., Kinoshita, N., Kinoshita, M., Kitamura, R., Kiyosue, A., Klavina, I., Klein, E. J., Klimsa, Z., Klonoff, D., Klug, E., Kobalava, Z., Kodera, S., Koga, T., Kokkinos, A., Koleckar, P., Könyves, L., Koren, M. J., Kormann, A. P., Kostner, K., Kreutzmann, K., Krishinan, S., Krishnasamy, S. S., Krivosheeva, I., Kruljac, I., Kubicki, T., Kuchar, L., Kujawiak, M., Kunishige, H., Kurtinecz, M., Kurtz Lisboa, H. R., Kushnir, M., Kyyak, Y., Lace, A., Lakka, T., Lalic, N., Lalic, K., Lambadiari, V., Lanaras, L., Lang, C., Langlois, M.-F., Lash, J., Latkovskis, G., Lau, D., Lazcano Soto, J. R., Le Roux, C., Ledesma, G. N., Lee, L. Y., Lee, T.-L., Lee, K., Lehrke, M., Leite, S. O., Leksycka, A., Lenzmeier, T., Leonetti, F., Leonidova, V., Lepor, N., Leung, M., Levchenko, O., Levins, P., Levy, L. J., Lewis, M., Liberopoulos, E., Liberty, I., Lindholm, C.-J., Lingvay, I., Linhart, A., Liu, M.-E., Liu, J., Lofton, H., Logemann, T., Lombaard, J. J., Lombard, L., Lorraine, R., Lovell, C. F., Ludvik, B., Lukaszewicz, M., Lupkovics, G., Lupovitch, S., Lupu, S., Lynch, M., Lysak, Z., Lysenko, T. A., Maeda, H., Maeda, I., Mæng, M., Mahajan, A. U., Maher, V., Maia, L. N., Makotoko, E. M., Malavazos, A., Malecha, J., Malicherova, E., Manita, M., Mannucci, E., Mareev, V., Marin, L., Markova, T., Marso, S. P., Martens, F. M. A. C., Martinez, C., Martinez Cano, C. A., Martins, C., Masmiquel Comas, L., Matsumoto, T., Mcdonald, K., Mcgowan, B., Mcgrew, F., Mclean, B. K., Mcpherson, D. D., Merino Torres, J. F., Meyers, P., Meyhöfer, S., Mezquita Raya, P., Milanova, M., Milicic, D., Miller, G., Mills, R. E., Mîndrescu, N. M., Mingrone, G., Minkova, D. A., Mirani, M., Miras, A., Mistodie, C. V., Mitomo, S., Mittal, S., Miyake, T., Miyamoto, N., Molony, D., Monteiro, P., Mooe, T., Moosa, N., Morales Portillo, C., Morales Villegas, E. C., Morawski, E. J., Morbey, C., Morin, R. P., Morisaki, K., Morosanu, M., Mosenzon, O., Mostovoy, Y., Munir, I., Muratori, F., Murray, R., Murthy, A., Myint, M., Myshanych, G., Nafornita, V., Nagano, T., Nair, S., Nakhle, S. N., Natsuaki, M., Nayak, B. M., Nibouche, D. E., Nicholls, S., Nicolau, J. C., Nicolescu, G., Nierop, P., Niskanen, L., Ntaios, G., Nygård, O. K., Oaks, J. B., Obrezan, A., O'donnell, P., Oguri, M., Oguzhan, A., Oh, F., Ohsugi, M., Okada, Y., Okayama, H., Onaca, A., Onaka, H., Oneil, P., Ong, T. K., Ong, S., Ono, Y., Opsahl, P. J., Ostrowska, L., Oviedo, A., Ozdogan, O., Ozpelit, E., Pagkalos, E., Pagotto, U., Páll, D., Pandey, A. S., Parkhomenko, O., Parvathareddy, K. M., Patel, M. B., Patsilinakos, S., Paul, N., Pedersen, S., Pereira, I., Pereira, E. S., Perez Terns, P., Perez-Vargas, E. A., Pergaeva, Y., Perkelvald, A., Peskov, A. B., Peter, J., Peters, K., Petit, C., Petrov, I., Philis-Tsimikas, A., Pietilä, M., Pinto, F., Piros, A., Piyayotai, D., Platonov, D., Poirier, P., Pop, L., Popa, B., Pop-Busui, R., Poremba, J., Porto, A., Postadzhiyan, A., Pothineni, R. B., Potu, R. P., Powell, T., Prafulla, K. G., Prager, R., Prakova-Teneva, Z. R., Pratley, R. E., Price, H., Pulka, G., Pullman, J., Punt, Z. E., Purighalla, R. S., Purnell, P., Qureshi, M., Rabasa-Lhoret, R., Raikhel, M. A., Rancane, G., Randeva, H., Rasouli, N., Reurean Pintilei, D. V., Reyes, C. R., Rezgale, I., Rice, E., Riley, T. H., Risser, J. A., Ristic, A., Rivas Fernández, M., Robbins, D., Robitaille, Y., Rodbard, H. W., Rodriguez Plazas, J. A., Römer, T. J., Rosen, G., Rosman, D. A., Rossi, P., Rudenko, L., Ruffin, O., Ruhani, A. I., Runev, N., Ruyatkin, D., Ruzic, A., Ryabov, V. V., Rydén, L., Saggar, S., Sakamoto, T., Salter, T., Samal, A. K., Samoilova, Y., Sanabria, H. D., Sancak, S., Sangrigoli, R., Sansanayudh, N., Santini, F., Saraiva, J. F., Sardinov, R., Sargeant, W., Sari, R., Sathananthan, A., Sathyapalan, T., Sato, A., Sauter, J., Sbraccia, P., Schaap, J., Schaum, T., Schiele, F., Scott, J., Segal Lieberman, G., Segner, A., Senior, R., Sergeeva-Kondrachenko, M. Y., Serota, H., Serusclat, P., Sethi, R., Shah, M. K., Shah, N., Shalaev, S., Sharma, R., Sharma, S., Shaydyuk, O., Shea, H. C., Shechter, M., Shehadeh, N., Shirazi, M., Shlesinger, Y., Shneker, A., Shutemova, E., Siasos, G., Siddiqui, I. A., Sidey, J., Sigal, F., Sime, I., Singh, N., Siraj, E., Sivalingam, K., Skoczylas, G., Smith, S. K., Smolenskaya, O., Snyder, B., Sofer, Y., Sofley, C. W., Solano, R., Sonmez, Y. A., Sorokin, M., Soto González, A., Sotolongo, C., Soufer, J., Soyluk Selcukbiricik, O., Spaic, T., Spriggs, D., Sreenan, S., Stahl, H.-D., Stamatelopoulos, K., Stanislavchuk, M., Stankovic, G., Stasek, J., Steg, G., Steindorf, J., Stephan, D., Stewart, J., Still, C., St-Maurice, F., Stogowska-Nikiciuk, B., Stoker, J., Stokic, E., Strzelecka, A., Sturm, K., Sueyoshi, A., Sugiura, T., Sultan, S., Suplotova, L. A., Suwanagool, A., Suwanwalaikorn, S., Sveklina, T., Swanson, N., Swart, H., Swenson, B. P., Szyprowska, E., Tait, G., Takács, R., Takeuchi, Y., Tamirisa, A., Tanaka, H., Tatovic, D., Tellier, G., Teragawa, H., Teterovska, D., Thomas, N., Thuan, J.-F., Tinahones, F., Tisheva-Gospodinova, S., Toarba, C., Todoriuk, L., Tokmakova, M., Tonstad, S., Toplak, H., Tran, H., Tripathy, D., Trusau, A., Tsabedze, N., Tsougos, E., Tsoukas, G. M., Tuccinardi, D., Tuna, M. M., Turatti, L. A., Tziomalos, K., Udommongkol, C., Ueda, O., Ukkola, O., Unubol, M., Urbach, D., Urina Triana, M. A., Usdan, L., Vaidya, B., Vale, N., Vallieres, G., Van Beek, A. P., Van De Borne, P., Van Der Walt, E., Van Der Zwaan, C., Van Nieuwenhuizen, E., Van Zyl, L., Vanduynhoven, P., Varghese, K., Vasileva, S. P., Vassilev, D., Vathesatogkit, P., Velychko, V., Vercammen, C., Verges, B., Verma, S., Verwerft, J., Vesela, A., Veselovskaya, N. G., Vettor, R., Veze, I., Vijan, V., Vijayaraghavan, R., Villarino, A., Vincent, R., Vinogradova, O., Vishlitzky, V., Vlad, A., Vladu, I. M., Vo, A., Von Engelhardt, C., Von Münchhausen, C., Vorobyeva, O., Vossenberg, T., Vrolix, M., Vukicevic, M., Vyshnyvetskyy, I., Wadvalla, S., Wagner, J., Wakeling, J., Wallace, J., Wan Mohamed, W. M. I., Wander, G. S., Ward, K., Warren, M. L., Watanabe, A., Weber, B., Weintraub, H., Weisnagel, J., Welker, J., Wendisch, U., Wenocur, H. S., Wierum, C., Wilding, J., William, M., Wilson, P., Wilson, J. P., Wong, Y.-K., Wongcharoen, W., Wozniak, I., Wu, C.-C., Wyatt, N., Wynne, A., Yamaguchi, H., Yamasaki, M., Yazici, D., Yeh, H.-I., Yotov, Y., Yuan, Q., Zacher, J., Zagrebelnaya, O., Zaidman, C. J., Zalevskaya, A., Zarich, S., Zatelli, M. C., Zeller, H., Zhdanova, E. A., Zornitzki, T., Zrazhevskiy, K., Zykov, M., Lincoff, A. M., Ryan, D. H., Colhoun, H. M., Deanfield, J. E., Emerson, S. S., Kahn, S. E., Kushner, R. F., Plutzky, J., Brown-Frandsen, K., Hovingh, G. K., Hardt-Lindberg, S., & Tornøe, C. W.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2024-08
- Volume
- 404
- Issue
- 10454
- Pages
- 773-786
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4401815221
- Cited by
- 275
- References
- 23
- FWCI
- 73.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Novo Nordisk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. https://app.cochat.ai/papers/10.1016/s0140-6736(24)01498-3
- The paper
- Deanfield, J., Verma, S., Scirica, B. M., Kahn, S. E., Emerson, S. S., Ryan, D., Lingvay, I., Colhoun, H. M., Plutzky, J., Kosiborod, M. N., Hovingh, G. K., Hardt-Lindberg, S., Frenkel, O., Weeke, P. E., Rasmussen, S., Goudev, A., Lang, C. C., Urina-Triana, M., Pietilä, M., . . . Tornøe, C. W. (2024). Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. The Lancet. https://doi.org/10.1016/s0140-6736(24)01498-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.